We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
VANI icon
351
Vivani Medical
VANI
$105M
$105M $1.16 3.57%
PYPD icon
352
PolyPid
PYPD
$103M
$103M $5.07 1.55%
IMUX icon
353
Immunic
IMUX
$102M
$102M $7.48 0.94%
LENZ icon
354
LENZ Therapeutics
LENZ
$101M
$101M $3.22 0.94%
CLLS icon
355
Cellectis
CLLS
$97.6M
$97.6M $0.9685 2.17%
COYA icon
356
Coya Therapeutics
COYA
$97.1M
$97.1M $4.14 1.66%
PLYX icon
357
Polaryx Therapeutics Inc
PLYX
$96.7M
$96.7M $1.94 1.57%
AARD icon
358
Aardvark Therapeutics
AARD
$96.5M
$96.5M $4.41 13.1%
ICCC icon
359
ImmuCell
ICCC
$95.5M
$95.5M $10.52 0.67%
ANIX icon
360
Anixa Biosciences
ANIX
$94.2M
$94.2M $2.71 1.12%
CNXU icon
361
Conexeu Sciences Inc
CNXU
$93.9M
$93.9M $3.33 11.4%
ATRA icon
362
Atara Biotherapeutics
ATRA
$93.9M
$93.9M $9.35 2.07%
GNLX icon
363
Genelux
GNLX
$93.7M
$93.7M $2.07 17.2%
OKUR icon
364
OnKure Therapeutics
OKUR
$93.1M
$93.1M $2.30 2.54%
TNXP icon
365
Tonix Pharmaceuticals
TNXP
$93.1M
$93.1M $5.43 6.06%
EQ icon
366
Equillium
EQ
$90M
$90M $1.42 2.9%
PDSB icon
367
PDS Biotechnology
PDSB
$89.9M
$89.9M $1.24 29.1%
TNYA icon
368
Tenaya Therapeutics
TNYA
$87.5M
$87.5M $0.3902 4.83%
MIST icon
369
Milestone Pharmaceuticals
MIST
$86.6M
$86.6M $0.6953 3.23%
RLYB icon
370
Rallybio
RLYB
$86.2M
$86.2M $16.22 0.98%
NTHI icon
371
NeOnc Technologies
NTHI
$83.5M
$83.5M $2.90 4.69%
CRBP icon
372
Corbus Pharmaceuticals
CRBP
$83M
$83M $4.29 2.94%
INO icon
373
Inovio Pharmaceuticals
INO
$82.2M
$82.2M $0.7953 21.3%
PMN icon
374
ProMIS Neurosciences
PMN
$81.9M
$81.9M $9.13 12.9%
OKYO icon
375
OKYO Pharma
OKYO
$80.8M
$80.8M $1.54 12.4%
13 14
15
16 17

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.28T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $133B, Moderna (MRNA) at $98.1B and Regeneron Pharmaceuticals (REGN) at $82.9B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.